Fortress Biotech, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.50
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.27
|
-0.25
|
0.02
|
7.41%
|
|
2022-06-30
|
-0.21
|
-0.24
|
-0.03
|
-14.29%
|
|
2022-03-31
|
-0.28
|
-0.18
|
0.10
|
35.71%
|
|
2021-12-31
|
0.18
|
-0.38
|
-0.56
|
-311.11%
|
|
2021-09-30
|
-0.08
|
-0.26
|
-0.18
|
-225.00%
|
|
2021-06-30
|
-0.12
|
-0.04
|
0.08
|
66.67%
|
|
2021-03-31
|
-0.11
|
-0.11
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.14
|
-0.05
|
0.09
|
64.29%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.67
|
|
2021-12-31
|
-0.79
|
|
2020-12-31
|
-0.63
|
|
2019-12-31
|
-0.71
|
|
2018-12-31
|
-1.94
|
|
2017-12-31
|
-1.62
|
|
2016-12-31
|
-1.38
|
|
2015-12-31
|
-1.24
|
|
2014-12-31
|
-0.57
|
|
2013-12-31
|
-1.24
|
|
2012-12-31
|
-1.25
|
|
2011-12-31
|
-1.00
|